Latest Myasthenia Gravis news
FDA Approves Zilbrysq for Generalized Myasthenia Gravis
posted October 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First-in-Class Treatment for Myasthenia Gravis
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Thymectomy + PDN Beneficial for Non-Thymomatous Myasthenia Gravis
posted January 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with non-thymomatous myasthenia gravis, thymectomy plus prednisone confers benefits versus prednisone alone at five years, according to a study published online Jan. 25 in The Lancet Neurology.
Editor's Recommendations
Active Smoking Linked to Progression of Sickle Cell Retinopathy 
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring 
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate 
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement 
Thymectomy Improves Outcomes in Myasthenia Gravis 
Autologous HSCT Can Result in Remission in Myasthenia Gravis Monthly Specialist Briefings
Stay Connected
